Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN360715 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) (C-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- This antibody is generated from rabbits immunized with a KLH conjugated syntheticpeptide at the C-term of human TRPM8.
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 0.1 mg
- Concentration
- 0.25 mg/ml
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf life: one year from despatch. Caution: This product is for research use only. Not for use in diagnostic or therapeutic procedures.
Submitted references Characterisation of TRPM8 as a pharmacophore receptor.
Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein trp-p8.
Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins.
Bödding M, Wissenbach U, Flockerzi V
Cell calcium 2007 Dec;42(6):618-28
Cell calcium 2007 Dec;42(6):618-28
Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein trp-p8.
Kiessling A, Füssel S, Schmitz M, Stevanovic S, Meye A, Weigle B, Klenk U, Wirth MP, Rieber EP
The Prostate 2003 Sep 1;56(4):270-9
The Prostate 2003 Sep 1;56(4):270-9
Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins.
Tsavaler L, Shapero MH, Morkowski S, Laus R
Cancer research 2001 May 1;61(9):3760-9
Cancer research 2001 May 1;61(9):3760-9
No comments: Submit comment
No validations: Submit validation data